Ingestible Thermometers Market size is set to record tremendous growth trajectory from 2023-2032 driven by the increasing application scope in post-surgical care and anesthesia.
Advanced ingestible thermometers are widely used in animal care, sports surgeries, and GI treatment. Over the recent past, the number of gastrointestinal tract (GI) disorders, such as Crohn’s disease and ulcerative colitis has increased dramatically, thus driving the demand for adequate care services and tools such as ingestible thermometers. In October 2022, BodyCap launched the new Intelligence & Ingestible Capsules Lab (ICI-Lab) in collaboration with UMR LIP6 to improve the screening of intestinal diseases.
Ingestible thermometers are also favored for monitoring the core body temperatures of firefighters, divers, and individuals working in adverse temperatures. In addition to healthcare, ingestible thermometers are gaining significant traction for critical temperature monitoring across the paper manufacturing and food processing sectors. However, the conflict between Russia and Ukraine is expected to introduce unprecedented supply chain disruptions and skyrocketing costs of raw materials, causing inflation and subsequently disrupting the ingestible thermometers market outlook to some extent.
Based on the product, the market share of rectal ingestible thermometers is anticipated to rise notably over 2032. Rectal thermometers offer a wide range of benefits, such as accurate temperature measurement in children and infants since oral temperature monitoring fails to provide accurate analysis and elevates the risk of injury. These devices are also used in veterinary medicines and pediatrics.
With regards to applications, the sleep disorder analysis segment will hold substantial share of the ingestible thermometers market through 2032 due to the surge in prevalence of sleep apnea. In the U.S. alone, obstructive sleep apnea affects more than 30 million adults, whereas the global prevalence exceeds billions. The ongoing advancements in wearable medical devices, AI and IoT-enabled tools, and electronic temperature pills (e-pills) will also spur product applications to treat and analyze sleep apnea patients, thereby driving the industry gains.
In terms of end-use, the ingestible thermometers industry is set to record substantial remuneration from ambulatory surgical centers (ASCs) over 2032. The rising admissions across ambulatory units and the growing preference for outpatient care will drive the segment value. These facilities offer better patient outcomes at reduced costs and deliver personalized care. With the growing disease burden globally, several countries are investing heavily in the expansion of ASCs, adding positive impetus to the ingestible thermometers market expansion.
For instance, in August 2022, the Department of Health & Social Care of the U.K. announced plans to build more than 50 new surgical hubs in England to overcome the backlog of procedures delayed by the emergence of the COVID-19 pandemic. The hubs will support more than 200,000 extra procedures in 2022-23 followed by an additional 700,000 procedures in 2023-24.
Asia Pacific industry is projected to record stellar growth over 2032 led by the surging geriatric population in India and China. As per the National Health Commission (NHC), China is expected to house more than 300 million older people by 2025 to emerge as a severely aging economy by 2035, accounting for 30% of the total population. Hence, the growing patient pool in the region is predicted to foster the demand for ingestible thermometers.
Some of the prominent players operating in the global ingestible thermometers market are Koninklijke Philips N.V., BodyCap, and HQ Inc. These firms are working on collaborations, mergers, partnerships, acquisitions, and product launches for gaining competitive edges and expanding their consumer base.